Patents by Inventor Carsten Foged Godtfredsen

Carsten Foged Godtfredsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030220251
    Abstract: This invention relates to a method for modulating, inhibiting or decreasing or preventing beta cell degeneration, loss of beta cell function, beta cell dysfunction, and/or death of beta cells, such as necrosis or apoptosis of beta cells in a subject comprising administering a GLP-1 agonist to said subject.
    Type: Application
    Filed: February 24, 2003
    Publication date: November 27, 2003
    Inventors: Liselotte Bjerre Knudsen, Carsten Foged Godtfredsen, Jacob Sten Petersen, Richard David Carr
  • Patent number: 6569832
    Abstract: This invention relates to a method for modulating, inhibiting or decreasing or preventing beta cell degeneration, loss of beta cell function, beta cell dysfunction, and/or death of beta cells, such as necrosis or apoptosis of beta cells in a subject comprising administering a GLP-1 agonist to said subject.
    Type: Grant
    Filed: November 10, 2000
    Date of Patent: May 27, 2003
    Assignee: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Carsten Foged Godtfredsen, Jacob Sten Petersen, Richard David Carr, Søren Bregenholt